PCA3 molecular urine assay for prostate cancer: association with pathologic features and impact of collection protocols

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: A randomized, open-label, parallel-group pilot study

(2009) Martijn P.M.Q. van Gils et al.   PROSTATE

Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer

(2009) Daphne Hessels et al.   PROSTATE

Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer

(2008) Ayman S. Moussa et al.   BJU INTERNATIONAL

Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results

(2008) Martijn P.M.Q. van Gils et al.   PROSTATE